Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions

Reduced lung function and risk of atrial fibrillation in The Copenhagen City Heart Study

P. Buch, J. Friberg, H. Scharling, P. Lange, E. Prescott
European Respiratory Journal 2003 21: 1012-1016; DOI: 10.1183/09031936.03.00051502
P. Buch
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Friberg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. Scharling
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. Lange
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E. Prescott
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Figures

  • Tables
  • Fig. 1.—
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.—

    Forced expiratory volume in one second % predicted (FEV1 % pred) and relative risk (RR) of hospital admission for new atrial fibrillation. Based on Cox regression model stratified by sex and age. Bars indicate the 95% confidence intervals. —: regression line.

Tables

  • Figures
  • Table 1—

    Baseline characteristics of the study population without pre-existing atrial fibrillation in accordance with the level of forced expiratory volume in one second (FEV1) % predicted

    CharacteristicsFEV1 % pred
    <60%60–80%≥80%
    Subjects n123838728320
    Females588 (47.5)2065 (53.3)4693 (56.4)
    Age yrs56.5±10.252.6±11.851.4±12.1
    BMI kg·m−225.4±4.925.4±4.425.0±3.9
    Systolic blood pressure mmHg141.3±23.0138.1±21.9135.8±21.2
    Diastolic blood pressure mmHg84.9±12.882.9±12.282.4±12.2
    Blood glucose mm·L−16.82±2.066.73±1.966.52±1.50
    FEV1/FVC %63.9±13.875.6±9.482.7±7.6
    Current smokers904 (73.0)2818 (72.8)4827 (58.0)
    Daily tobacco consumption g#12.0±10.612.1±10.69.0±10.4
    Exsmokers186 (15.1)515 (13.3)1517 (18.3)
    Chest pain at activity317 (25.6)566 (14.6)739 (8.9)
    Diabetes66 (5.3)140 (3.6)168 (2.0)
    Treated with diuretics165 (13.5)348 (9.0)615 (7.4)
    Education <9 yrs of school1003 (81.3)2636 (68.2)4833 (58.2)
    • Data are presented as mean±sd or n (%) unless otherwise indicated

    • BMI: body mass index

    • #: among current smokers

    • For all characteristics p<0.001

  • Table 2—

    Presence of atrial fibrillation (AF) at baseline, at re-examination and at incident hospitalisations according to lung function

    FEV1 % pred
    <60%60–80%≥80%
    At baseline
     Subjects n125339048351
     Presence of AF15 (1.20)32 (0.82)31 (0.37)
    At re-examination
     Subjects n80929476910
     Presence of AF9 (1.11)25 (0.85)28 (0.41)
    At hospital admission
     Subjects n116736998315
     All cases of AF47 (4.03)96 (2.60)147 (1.77)
     AF as main diagnosis46 (3.94)28 (0.76)19 (0.23)
    • Data are presented as n (%) unless otherwise stated

    • FEV1 % pred: forced expiratory volume in one second % predicted

  • Table 3—

    Reduced lung function and odds ratio (95% confidence interval) of atrial fibrillation at re-examination after 5 yrs

    VariableModel 1#Model 2¶
    Age+1.07 (1.04–1.09)***1.06 (1.03–1.08)***
    Females1 (1)1 (1)
    Males2.62 (1.53–4.48)***2.38 (1.37–4.14)**
    FEV1 % pred
     ≥80%1 (1)1 (1)
     60–80%1.94 (1.13–3.34)*1.75 (1.01–3.05)*
     <60%2.03 (0.95–4.34)1.64 (0.74–3.65)
    • Data are presented as odds ratio (95% confidence interval)

    • FEV1 % pred: forced expiratory volume in one second % predicted

    • #: adjusted only for sex and age

    • ¶: adjusted for sex, age, systolic blood pressure, diabetes and body mass index

    • +: per 10-yr increase

    • *: p<0.05

    • **: p<0.01

    • ***: p<0.001

  • Table 4—

    Reduced lung function and relative risk (RR) (95% confidence interval (CI)) of incident atrial fibrillation (AF) hospitalisation

    New AF hospitalisationModel 1#Model 2¶
    FEV1 % predRR (95% CI)RR (95% CI)
    All cases of≥80%1 (1)1 (1)
    AF60–80%1.46 (1.13–1.89)**1.31 (1.00–1.70)*
    <60%2.14 (1.54–2.98)***1.82 (1.29–2.56)**
    AF as main≥80%1 (1)1 (1)
    diagnosis60–80%1.37 (0.85–2.19)1.28 (0.79–2.06)
    <60%2.83 (1.65–4.85)***2.53 (1.45–4.42)**
    • Results are from Cox proportional hazards regression analysis

    • FEV1 % pred: forced expiratory volume in one second % predicted

    • #: stratified by sex, adjusted only for age

    • ¶: stratified by sex and adjusted for age, systolic blood pressure, diabetes, treatment with diuretics, body mass index, chest pain, smoking and education

    • *: p<0.05

    • **: p<0.01

    • ***: p<0.001

PreviousNext
Back to top
View this article with LENS
Vol 21 Issue 6 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Reduced lung function and risk of atrial fibrillation in The Copenhagen City Heart Study
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Reduced lung function and risk of atrial fibrillation in The Copenhagen City Heart Study
P. Buch, J. Friberg, H. Scharling, P. Lange, E. Prescott
European Respiratory Journal Jun 2003, 21 (6) 1012-1016; DOI: 10.1183/09031936.03.00051502

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Reduced lung function and risk of atrial fibrillation in The Copenhagen City Heart Study
P. Buch, J. Friberg, H. Scharling, P. Lange, E. Prescott
European Respiratory Journal Jun 2003, 21 (6) 1012-1016; DOI: 10.1183/09031936.03.00051502
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Effects of cannabis on lung function: a population-based cohort study
  • Impact of influenza vaccination on mortality risk among the elderly
  • Vehicle exhaust outside the home and onset of asthma among adults
Show more Original Articles: Epidemiology

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • CME
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2021 by the European Respiratory Society